LYME QUANTITATIVE C6 PEPTIDE TEST
The Lyme C6- Peptide ELISA Test is the newest entry in Lyme disease testing accuracy. The Lyme C6 Peptide ELISA is very different that the earlier Lyme ELISA test. It was developed at Tulane University and available since 2000.
It can confirm exposure in more that 60% of patients.
The chance of a false positive result in under 1%.
While this new test when positive can confirm that an individual is infected with Lyme disease, unfortunately there is still no test clinically available that when negative proves that an individual does NOT have Lyme disease.
The Lyme C6- Peptide ELISA Test is the newest entry in Lyme disease testing accuracy. The Lyme C6 Peptide ELISA is very different that the earlier Lyme ELISA test. It was developed at Tulane University and available since 2000.
It can confirm exposure in more that 60% of patients.
The chance of a false positive result in under 1%.
While this new test when positive can confirm that an individual is infected with Lyme disease, unfortunately there is still no test clinically available that when negative proves that an individual does NOT have Lyme disease.
